美国 · SEC FORM 4
IRIDEX CORP
IRIX · Nasdaq · CIK 0001006045 · Healthcare · Medical Devices
内部人信号
1 位买方 · 11 条买入交易行 · $31.4K 买入总额
为什么有这个信号？
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
哪些因素限制了当前分数？
- ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
- ⚠ Purchase size is modest relative to the model scale
- ✓ 角色得分高 · 买入者中职位最高的是：Chief Financial Officer
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: Chief Financial Officer. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 42.2
- 42.0
- 41.9
- 41.8
- 41.5
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- +30.9%
- 3M
- -16.8%
- 6M
- -11.0%
- 12M
- -18.3%
波动率与流动性
- 波动率
- 79.2%
- Beta
- —
- 平均每日成交额
- USD 353,049
估值
- 市值
- USD 15.6M
- P/E
- —
基本面
- 利润率
- -8.4%
- ROE
- -90.1%
- 细分行业
- Medical Devices
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, 利润率, ROE · 财年截止日：2026-01-03 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-08-13 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 131,655
- 上期报告
- 160,330
- 日均成交量
- 37,757
- 回补天数
- 3.5
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-16 | Dizon Romeo R | 买入 (P) | Common Stock | 7,900 | USD 0.63 | USD 4,977 | SEC 申报 ↗ |
| 2026-09-14 | Dizon Romeo R | 买入 (P) | Common Stock | 2,354 | USD 0.65 | USD 1,530 | SEC 申报 ↗ |
| 2026-09-10 | Dizon Romeo R | 买入 (P) | Common Stock | 5,100 | USD 0.68 | USD 3,468 | SEC 申报 ↗ |
| 2026-08-24 | Dizon Romeo R | 买入 (P) | Common Stock | 1,300 | USD 0.75 | USD 975 | SEC 申报 ↗ |
| 2026-08-24 | Dizon Romeo R | 买入 (P) | Commn Stock | 5,368 | USD 0.75 | USD 4,026 | SEC 申报 ↗ |
| 2026-06-12 | Dizon Romeo R | 买入 (P) | Common Stock | 975 | USD 1.14 | USD 1,112 | SEC 申报 ↗ |
| 2026-06-11 | Dizon Romeo R | 买入 (P) | Common Stock | 1,675 | USD 1.14 | USD 1,909 | SEC 申报 ↗ |
| 2026-06-08 | Dizon Romeo R | 买入 (P) | Common Stock | 2,400 | USD 1.12 | USD 2,688 | SEC 申报 ↗ |
| 2026-06-05 | Dizon Romeo R | 买入 (P) | Common Stock | 2,521 | USD 1.15 | USD 2,899 | SEC 申报 ↗ |
| 2026-06-03 | Dizon Romeo R | 买入 (P) | Common Stock | 2,400 | USD 1.17 | USD 2,808 | SEC 申报 ↗ |
| 2026-05-26 | Dizon Romeo R | 买入 (P) | Common Stock | 5,004 | USD 1.00 | USD 5,004 | SEC 申报 ↗ |
| 2026-03-30 | Lin Shih-Yao David | 买入 (P) | Common Stock | 7,371 | USD 0.99 | USD 7,297 | SEC 申报 ↗ |
| 2026-03-24 | Lin Shih-Yao David | 买入 (P) | Common Stock | 4,549 | USD 1.33 | USD 6,050 | SEC 申报 ↗ |
| 2026-03-23 | Lin Shih-Yao David | 买入 (P) | Common Stock | 17,526 | USD 1.33 | USD 23,310 | SEC 申报 ↗ |
| 2026-03-17 | Lin Shih-Yao David | 买入 (P) | Common Stock | 22,805 | USD 1.31 | USD 29,872 | SEC 申报 ↗ |
Form 4 申报证据
97 transaction lines in the latest 365-day window; 329 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Lin Shih-Yao David; Novel Inspiration International Co., Ltd. | J (J) | Common Stock | 146,313 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-01 | Mercer Patrick | 代扣税 (F) | Common Stock | 23,917 | USD 0.63 | USD 15,116 | SEC 申报 ↗ |
| 2026-09-16 | Dizon Romeo R | 买入 (P) | Common Stock | 7,900 | USD 0.63 | USD 4,977 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Lin Shih-Yao David; Novel Inspiration International Co., Ltd. | J (J) | Common Stock | 146,313 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-01 | Mercer Patrick | 代扣税 (F) | Common Stock | 23,917 | USD 0.63 | USD 15,116 | SEC 申报 ↗ |
| 2026-09-16 | Dizon Romeo R | 买入 (P) | Common Stock | 7,900 | USD 0.63 | USD 4,977 | SEC 申报 ↗ |
| 2026-09-14 | Dizon Romeo R | 买入 (P) | Common Stock | 2,354 | USD 0.65 | USD 1,530 | SEC 申报 ↗ |
| 2026-09-10 | Dizon Romeo R | 买入 (P) | Common Stock | 5,100 | USD 0.68 | USD 3,468 | SEC 申报 ↗ |
| 2026-08-24 | Dizon Romeo R | 买入 (P) | Common Stock | 1,300 | USD 0.75 | USD 975 | SEC 申报 ↗ |
| 2026-08-24 | Dizon Romeo R | 买入 (P) | Commn Stock | 5,368 | USD 0.75 | USD 4,026 | SEC 申报 ↗ |
| 2026-07-10 | Mercer Patrick | 奖励／授予 (A) | Common Stock | 100,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-10 | Dizon Romeo R | 奖励／授予 (A) | Common Stock | 30,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-07 | Lin Shih-Yao David; Novel Inspiration International Co., Ltd. | J (J) | Common Stock | 111,997 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-13 | Mercer Patrick | 代扣税 (F) | Common Stock | 3,990 | USD 1.12 | USD 4,469 | SEC 申报 ↗ |
| 2026-06-13 | Dizon Romeo R | 代扣税 (F) | Common Stock | 2,691 | USD 1.12 | USD 3,014 | SEC 申报 ↗ |
| 2026-06-12 | Dizon Romeo R | 买入 (P) | Common Stock | 975 | USD 1.14 | USD 1,112 | SEC 申报 ↗ |
| 2026-06-11 | Dizon Romeo R | 买入 (P) | Common Stock | 1,675 | USD 1.14 | USD 1,909 | SEC 申报 ↗ |
| 2026-06-08 | Dizon Romeo R | 买入 (P) | Common Stock | 2,400 | USD 1.12 | USD 2,688 | SEC 申报 ↗ |
| 2026-06-05 | Dizon Romeo R | 买入 (P) | Common Stock | 2,521 | USD 1.15 | USD 2,899 | SEC 申报 ↗ |
| 2026-06-03 | Dizon Romeo R | 买入 (P) | Common Stock | 2,400 | USD 1.17 | USD 2,808 | SEC 申报 ↗ |
| 2026-05-26 | Mercer Patrick | 代扣税 (F) | Common Stock | 19,233 | USD 1.01 | USD 19,425 | SEC 申报 ↗ |
| 2026-05-26 | Dizon Romeo R | 买入 (P) | Common Stock | 5,004 | USD 1.00 | USD 5,004 | SEC 申报 ↗ |
| 2026-04-01 | Lin Shih-Yao David; Novel Inspiration International Co., Ltd. | J (J) | Common Stock | 87,949 | USD — | USD — | SEC 申报 ↗ |
| 2026-03-30 | Lin Shih-Yao David | 买入 (P) | Common Stock | 7,371 | USD 0.99 | USD 7,297 | SEC 申报 ↗ |
| 2026-03-24 | Lin Shih-Yao David | 买入 (P) | Common Stock | 4,549 | USD 1.33 | USD 6,050 | SEC 申报 ↗ |
| 2026-03-23 | Lin Shih-Yao David | 买入 (P) | Common Stock | 17,526 | USD 1.33 | USD 23,310 | SEC 申报 ↗ |
| 2026-03-17 | Lin Shih-Yao David | 买入 (P) | Common Stock | 22,805 | USD 1.31 | USD 29,872 | SEC 申报 ↗ |
| 2026-03-16 | Lin Shih-Yao David | 买入 (P) | Common Stock | 1,682 | USD 1.30 | USD 2,187 | SEC 申报 ↗ |
| 2026-03-12 | Lin Shih-Yao David | 买入 (P) | Common Stock | 967 | USD 1.32 | USD 1,276 | SEC 申报 ↗ |
| 2026-03-06 | Dizon Romeo R | 买入 (P) | Common Stock | 1,110 | USD 1.26 | USD 1,399 | SEC 申报 ↗ |
| 2026-03-03 | Lin Shih-Yao David | 买入 (P) | Common Stock | 752 | USD 1.42 | USD 1,068 | SEC 申报 ↗ |
| 2026-03-02 | Lin Shih-Yao David | 买入 (P) | Common Stock | 1,424 | USD 1.40 | USD 1,994 | SEC 申报 ↗ |
| 2026-02-23 | Lin Shih-Yao David | 买入 (P) | Common Stock | 14,943 | USD 1.41 | USD 21,070 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | IRIX |
| CIK | 0001006045 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3845 Electromedical & Electrotherapeutic Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 329 transaction lines from 2020-01-30 to 2026-10-02 228 P purchase lines · 0 S sale lines · 101 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.